
NK Cell Activity Predicts Treatment Response to CAR-T Therapy in Recurrent Glioblastoma
AI-generated image. Activation of natural killer (NK) cells may predict treatment response in patients with recurrent glioblastoma (GBM) receiving CAR-T cell therapy, while regulatory T cells (Tregs) appear to be a major cause of resistance, according to a study. Researchers at t
2026-06-18











